Frederick R. Kinder
Novartis (United States)(US)
Publications by Year
Research Areas
Synthetic Organic Chemistry Methods, Peptidase Inhibition and Analysis, Cyclopropane Reaction Mechanisms, Ubiquitin and proteasome pathways, Cancer Treatment and Pharmacology
Most-Cited Works
- → Proteomics-based Target Identification(2003)144 cited
- → Large-Scale Synthesis of the Anti-Cancer Marine Natural Product (+)-Discodermolide. Part 5: Linkage of Fragments C1-6 and C7-24 and Finale(2003)142 cited
- → Large-Scale Synthesis of the Anti-Cancer Marine Natural Product (+)-Discodermolide. Part 1: Synthetic Strategy and Preparation of a Common Precursor(2003)103 cited
- → Rhodium(II)-catalyzed cyclization of 2-alkynyl 2-diazo-3-oxobutanoates as a method for synthesizing substituted furans(1993)91 cited
- → Large-Scale Synthesis of the Anti-Cancer Marine Natural Product (+)-Discodermolide. Part 4: Preparation of Fragment C7-24(2003)86 cited
- → Bengamides Revisited: New Structures and Antitumor Studies(2001)80 cited
- → Total Synthesis of (.+-.)-Illudin M(1994)75 cited
- → Large-Scale Synthesis of the Anti-Cancer Marine Natural Product (+)-Discodermolide. Part 3: Synthesis of Fragment C15-21(2003)66 cited
- → Large-Scale Synthesis of the Anti-Cancer Marine Natural Product (+)-Discodermolide. Part 2: Synthesis of Fragments C1-6 and C9-14(2003)66 cited
- → Synthesis and Antitumor Activity of Ester-Modified Analogues of Bengamide B(2001)63 cited